Recently, studies have shown that CXCL10 over-expression is a distinct gene signature of acute-phase graft injury and tumor invasiveness in small-for-size liver grafts and that it can induce EPC mobilization, differentiation and neo-vessel formation, which further promotes tumor recurrence after liver transplantation [30, 31]. This evidence concerns the gene CXCL10 and neoplasm.